Home/OncoBone Therapeutics/Dr. Tiina Kähkönen, Ph.D.

DT

Dr. Tiina Kähkönen, Ph.D.

Chief Scientific Officer

OncoBone Therapeutics

Therapeutic Areas

Oncology Rare Disease

OncoBone Therapeutics Pipeline

Drug	Indication	Phase
OBP-004	Bone Metastasis (and other metastases)	Preclinical

Leadership Team at OncoBone Therapeutics

Dr. Jussi Halleen, Ph.D.

Chief Executive Officer

View full OncoBone Therapeutics profile